Study Protocol
Accepted on 13 May 2026
Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: Study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome (HACOL-ACS) trial
in Lipids in Cardiovascular Disease